Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
ZAI Lab
Welcome,
Profile
Billing
Logout
3 Products
67 Diseases
3 Products
4 Trials
110 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
28
56
84
112
140
168
196
224
252
280
Zejula
(niraparib) / GSK, J&J
Zynyz
(retifanlimab-dlwr) / Incyte
Vyvgart
(efgartigimod alfa-fcab) / argenx, Broteio
Krazati
(adagrasib) / BMS
Cobenfy
(xanomeline/trospium) / BMS
Vyvgart Hytrulo
(efgartigimod alfa and hyaluronidase-qvfc) / argenx
brivanib alaninate
(BMS-582664) / BMS
Nuzyra
(omadacycline) / Paratek Pharmaceuticals
Qinlock
(ripretinib) / Ono Pharma
bemarituzumab
(AMG 552) / Amgen
Augtyro
(repotrectinib) / BMS
Ordspono
(odronextamab) / Regeneron
Tivdak
(tisotumab vedotin-tftv) / Genmab, Pfizer
Margenza
(margetuximab-cmkb) / TerSera Therap
veligrotug
(VRDN-001) / Viridian Therap
tebotelimab
(MGD013) / MacroGenics
Xacduro
(sulbactam-durlobactam) / Innoviva
povetacicept
(ALPN-303) / Vertex
zipalertinib
(CLN-081) / Cullinan Therap, Otsuka
simurosertib
(TAK-931) / Takeda, ZAI Lab
ZL-1102
/ ZAI Lab
tigozertinib
(BLU-945) / Blueprint Medicines
BLU-701
/ Blueprint Medicines
ZL-1201
/ ZAI Lab
ZL-1211
/ ZAI Lab
ZL-1218
/ ZAI Lab
ZL-2102
/ ZAI Lab
elzovantinib
(TPX-0022) / BMS
